Attributing Responsibility for the Nerve Agent Attack in the United Kingdom
- Details
- Written by State Department
- Category: News
Washington, DC - Secretary of State Rex W. Tillerson: "The United States was in touch with our Allies in the United Kingdom ahead of today’s announcement, including in a call between Secretary Tillerson and Foreign Secretary Johnson this morning. We have full confidence in the UK’s investigation and its assessment that Russia was likely responsible for the nerve agent attack that took place in Salisbury last week.
CDFA appeals court decision on PEIR for Plant Health and Pest Prevention Services division
- Details
- Written by Imperial Valley News
- Category: News
Sacramento, California - CDFA has filed an appeal of a recent Superior Court decision invalidating portions of CDFA’s Programmatic Environmental Impact Report for Pest Prevention and Management.
United States To Seek International Progress on Combating the Opioid Crisis at 61st UN Commission on Narcotic Drugs
- Details
- Written by State Department
- Category: News
Vienna, Austria - Deputy Assistant Secretary of State for International Narcotics and Law Enforcement Affairs James A. Walsh will lead the U.S. delegation to the 61st UN Commission on Narcotic Drugs (CND), March 12-16, in Vienna, Austria. At the CND, the United States will push to secure international control of carfentanil, a particularly lethal fentanyl analogue that is contributing to thousands of deaths in the United States; and will also sponsor a resolution aimed at mobilizing a global response to the opioid crisis.
Goal to fusion power on the fast track
- Details
- Written by David Chandler
- Category: News
Cambridge, Massachusetts - Progress toward the long-sought dream of fusion power - potentially an inexhaustible and zero-carbon source of energy - could be about to take a dramatic leap forward.
Monoclonal antibodies crucial to fighting emerging infectious diseases
- Details
- Written by Elizabeth Deatrick
- Category: News
Washington, DC - Monoclonal antibodies (mAbs) - preparations of a specific type of antibody designed to bind to a single target - have shown promise in the fight against cancer and autoimmune diseases. They also may play a critical role in future battles against emerging infectious disease outbreaks, according to a new article by scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The article is published online this week by the New England Journal of Medicine and outlines the potential uses for mAbs as treatments for infectious diseases and as a prevention tool for protecting individuals at risk of infection and slowing disease outbreaks.
On Twitter, false news travels faster than true stories
- Details
- Written by Peter Dizikes
- Category: News
Cambridge, Massachusetts - A new study by three MIT scholars has found that false news spreads more rapidly on the social network Twitter than real news does — and by a substantial margin.
Page 980 of 3785